Shares in 4D Medical have soared up to 33%, after the US FDA approved the company’s CT:VQ lung imaging test for ventilation perfusion. The news sent 4D shares soaring up to 40%. 4D Medical describes ...
CT perfusion and angiography failed to meet sensitivity and specificity thresholds to determine brain death. Neither should be used as standalone tests to establish death by neurologic criteria, the ...
CT LVAS scans, analyzes CT images providing rich data on regional lung function—enables radiologists to furnish new levels of quantified, data-based correlation between function and structure to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results